Effect of age on reasons for initiation and discontinuation of hormone replacement therapy

Menopause

Volumn 6, Issue 4, 1999, Pages 282-289

  Ettinger, Bruce ^a   Pressman, Alice ^a   Silver, Paula ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

Age Factors; Climacteric; Hormone Replacement Therapy; Osteoporosis; Patient Compliance

Indexed keywords

ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; CLIMACTERIUM; DEPRESSION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; PATIENT COMPLIANCE; VAGINA BLEEDING; VAGINA DISCHARGE;

EID: 0033460299     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-199906040-00003     Document Type: Article

References (16)

1. Ettinger B, Li D-K, Klein R. Continuation of postmenopausal hormone replacement therapy: comparison of cyclic versus continuous combined schedules. Menopause 1996;3:185-9,
2. Utian WH, Schiff I. NAMS-Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 1994;1:39-48.
3. Groeneveld FPMJ, Bareman FP, Barentsen R, Dokter HJ, Drogendijk AC, Hoes AW. Determinants of first prescription of hormone replacement therapy: a follow-up study among 1689 women aged 45-60 years. Maturitas 1995;20:81-9.
4. Berman RS, Epstein RS, Lydick EG. Compliance of women in taking estrogen replacement therapy. J Womens Health 1996;5:213-20.
5. Karakoç B, Erenus M. Compliance considerations with hormone replacement therapy. Menopause 1998;5:102-6.
6. Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439-52.
7. Cauley JA, Seeley DG, Ensrud K, et al. Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9-16.
8. Schneider DL, Barrett-Connor EL, Morton DJ. Timing of postmenopausal estrogen for optimal bone mineral density: the Rancho Bernardo Study. JAMA 1997;277:543-7.
9. Wallace WA, Price VH, Elliot CA, MacPherson MBA, Scott BW. Hormone replacement therapy acceptability to Nottingham postmenopausal women with a risk factor for osteoporosis. J R Soc Med 1990;83:699-701.
10. Faulkner DL, Young C, Hutchins D, McCollam JS. Patient non-compliance with hormone replacement therapy: a nationwide estimate using a large prescription claims database. Menopause 1998;4:226-9.
11. Silverman SL, Greenwald M, Klein RA, Drinkwater BL. Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol 1997;89:321-5.
12. Rubin SM, Cummings SR. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990-5.
13. Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol 1992;99:325-8.
14. Ettinger B, Li D-K, Klein R. Unexpected vaginal bleeding and associated gynecologic care in postmenopausal women using hormone replacement therapy: comparison of cyclic versus continuous combined schedules. Fertil Steril 1998;69:865-9.
15. Walsh BW, Kuller LH, Wild RA, et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998;279:1445-51.
16. Achieving long-term continuance of menopausal ERT/HRT: consensus opinion of the North American Menopause Society. Menopause 1998;5:69-76.